Genmab A/S buy tbackenh
Start price
14.03.14
/
50%
€31.91
Target price
18.03.14
€37.50
Performance (%)
0.00%
End price
18.03.14
€31.91
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Genmab A/S | 8.813% | 8.813% | 43.746% | -28.292% |
| iShares Core DAX® | 2.480% | 1.738% | 6.882% | 55.581% |
| iShares Nasdaq 100 | -0.982% | -2.736% | 33.971% | 86.280% |
| iShares Nikkei 225® | -4.893% | 1.345% | 57.015% | 72.651% |
| iShares S&P 500 | 1.062% | 0.054% | 25.183% | 65.844% |
Comments by tbackenh for this prediction
In the thread Genmab A/S diskutieren
Genmab AS
Biotechnologie aus dem Nachbarland Dänemark! Trotz der relativ kleinen Marktkapitalisierung ein interessanter Wert mit guten Wachstumsaussichten.